The board of directors of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) decided, on Feb. 24, a 14.6% cash dividend for the second half of 2024, at SAR 1.46 per share, as shown below:
|
Dividend (H2 2024) |
|
|
Current Capital |
SAR 700 mln |
|
Number of Shares |
70 mln |
|
Total Dividends |
SAR 102 mln |
|
Percentage of Capital |
14.6% (SAR 1.46 per share) |
|
Record Date |
March 4, 2025 |
|
Payout Date |
March 17, 2025 |
|
Total Dividends (2024) |
|
|
Total dividend |
SAR 214 mln |
|
Percentage of capital |
30.6% (SAR 3.06 per share) |
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 25/02/2025 | 04/03/2025 | 17/03/2025 | 102.20 | 1.46 | |
| 06/08/2024 | 15/08/2024 | 25/08/2024 | 112.00 | 1.60 | |
| 04/04/2024 | 04/06/2024 | 13/06/2024 | 105.00 | 1.50 | |
| 10/08/2023 | 20/08/2023 | 03/09/2023 | 70.00 | 1.00 |
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | N/A | N/A | N/A |
| Last 5 Financial years | N/A | N/A | N/A |
| Last 10 Financial years | N/A | N/A | N/A |
| P/E (TTM) | 33.14 |
| P/E Before Unusual Items (TTM) | 33.14 |
| P/BV | 7.93 |
| Dividend Yield | 2.01 % |
| Market Cap. (M) | 11,816.00 |
| Return on Average Assets | 20.81 % |
| Return on Average Equity | 22.67 % |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}